Malignant hyperthermia following systemic rewarming after hypothermic cardiopulmonary bypass

被引：17
|
作者：
Lichtman, AD
Oribabor, C
机构：
[1] Weill Cornell Med Ctr, Dept Anesthesiol, New York, NY USA
[2] New York Methodist Hosp, Cardiothorac Intens Care Unit, Brooklyn, NY USA
来源：
ANESTHESIA AND ANALGESIA | 2006年 / 102卷 / 02期
关键词：
D O I：
10.1213/01.ane.0000189596.70694.36
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
Malignant hyperthermia (MH) is a rare hypermetabolic disorder of skeletal muscle that can be fatal if not recognized and treated aggressively. We describe a patient with a suspected family history of MH who developed hyperpyrexia, acidosis, and hypermetabolism after cardiac surgery despite a nontriggering anesthetic. No drugs were identified as being causative and we theorize that systemic rewarming was the inciting cause of MH in this MH-susceptible individual via a mechanism similar to heat stroke.
引用
收藏
页码：372 / 375
页数：4
相关论文
共 50 条
  • [1] REWARMING FOLLOWING HYPOTHERMIC CARDIOPULMONARY BYPASS IN THE MALIGNANT HYPERTHERMIA-SUSCEPTIBLE PATIENT - IMPLICATIONS FOR DIAGNOSIS AND PERIOPERATIVE MANAGEMENT
    ALLEN, GC
    CATTRAN, CB
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1989, 36 (01): : 81 - 85
  • [2] Can we prevent malignant hyperthermia after hypothermic cardiopulmonary bypass in a malignant hyperthermia-susceptible patient?
    Siddik-Sayyid, Sahar M.
    Moussa, Adib R.
    Baraka, Anis S.
    ANESTHESIA AND ANALGESIA, 2007, 104 (01): : 214 - 214
  • [3] Successful Management of Hypothermic Cardiopulmonary Bypass in a Malignant Hyperthermia Susceptible Patient
    Agarwal, Shvetank
    Graham, Kevin
    Kigwana, Simon
    Castresana, Manuel
    ANNALS OF CARDIAC ANAESTHESIA, 2020, 23 (03) : 367 - 371
  • [4] Delayed Development of Malignant Hyperthermia Following Cardiopulmonary Bypass
    Sams, Stephen Hall
    Revilla, Stephen
    Stahl, David Lawrence
    SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2018, 22 (01) : 95 - 99
  • [5] Earlier extubation using axillary temperature as the endpoint for rewarming following hypothermic cardiopulmonary bypass
    MA Kai
    MJ Herbertson
    RS Gill
    Critical Care, 5 (Suppl 1):
  • [6] Propofol reduces oxygen consumption during postoperative rewarming following hypothermic cardiopulmonary bypass
    Milne, SE
    James, KS
    Nimmo, S
    Hickey, S
    BRITISH JOURNAL OF ANAESTHESIA, 1999, 82 : 50 - 50
  • [7] End-point temperature of rewarming after hypothermic cardiopulmonary bypass in pediatric patients
    Kim, WG
    Yang, JH
    ARTIFICIAL ORGANS, 2005, 29 (11) : 876 - 879
  • [8] CARDIOPULMONARY BYPASS IN TREATMENT OF MALIGNANT HYPERTHERMIA
    RYAN, JF
    DONLON, JV
    MALT, RA
    BLAND, JHL
    BUCKLEY, MJ
    SRETER, FA
    LOWENSTEIN, E
    NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (20): : 1121 - 1122
  • [9] CEREBROVASCULAR REACTIVITY IS IMPAIRED DURING REWARMING FROM HYPOTHERMIC CARDIOPULMONARY BYPASS
    VANDERMAATEN, JMAA
    HUYZEN, RJ
    HUET, RCGG
    BRITISH JOURNAL OF ANAESTHESIA, 1995, 74 : 18 - 18
  • [10] Pharmacological vasodilatation improves efficiency of rewarming from hypothermic cardiopulmonary bypass
    Deakin, CD
    Petley, GW
    Smith, D
    BRITISH JOURNAL OF ANAESTHESIA, 1998, 81 (02) : 147 - 151
12345